| Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model (NCT03511105) | GlaxoSmithKline | 2018-06-25 |
| NUCALA® Special Drug Use Investigation (EGPA, Long-term) (NCT03557060) | GlaxoSmithKline | 2018-06-25 |
| A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03478683) | GlaxoSmithKline | 2018-06-25 |
| A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03478696) | GlaxoSmithKline | 2018-06-25 |
| To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers (NCT03543137) | GlaxoSmithKline | 2018-06-18 |
| A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy Smokers (NCT03541044) | GlaxoSmithKline | 2018-06-18 |
| An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With Asthma (NCT03478657) | GlaxoSmithKline | 2018-06-18 |
| A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 Antibody (NCT03525678) | GlaxoSmithKline | 2018-06-18 |
| Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function (NCT03562117) | GlaxoSmithKline | 2018-06-14 |
| Adelphi Primary Sjogren's Syndrome (pSS) Disease Specific Programme (DSP) (NCT03501420) | GlaxoSmithKline | 2018-06-13 |
| Study of Renin-angiotensin System in Mechanically Ventilated Subjects (NCT03212690) | GlaxoSmithKline | 2018-06-11 |
| A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022 (NCT03563183) | GlaxoSmithKline | 2018-06-05 |
| A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis (NCT02671188) | GlaxoSmithKline | 2018-06-01 |
| Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness (NCT03543176) | GlaxoSmithKline | 2018-05-31 |
| A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects (NCT03438006) | GlaxoSmithKline | 2018-05-31 |
| Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects (NCT03329573) | GlaxoSmithKline | 2018-05-30 |
| Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia (NCT03188458) | GlaxoSmithKline | 2018-05-29 |
| Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT) (NCT03555890) | GlaxoSmithKline | 2018-05-18 |
| Immunogenicity and Persistence of GlaxoSmithKline (GSK) Biologicals' Havrix® in Healthy Adult Subjects Vaccinated at Infancy Under the Hepatitis A Universal Mass Vaccination (UMV) Program in Israel (NCT03183492) | GlaxoSmithKline | 2018-05-07 |
| Extended Access of Momelotinib in Adults With Myelofibrosis (NCT03441113) | GlaxoSmithKline | 2018-05-03 |
| Daprodustat Bioequivalence and Food Effect Study (NCT03493386) | GlaxoSmithKline | 2018-04-24 |
| Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions (NCT03465332) | GlaxoSmithKline | 2018-04-19 |
| The Extended Salford Lung Study ("Ex-SLS") Data Access Project (NCT03152669) | GlaxoSmithKline | 2018-04-15 |
| The Safety of Boostrix Following Routine Immunization of Pregnant Women (NCT03463577) | GlaxoSmithKline | 2018-04-13 |
| Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older (NCT03439657) | GlaxoSmithKline | 2018-04-12 |
| INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice Design (NCT03467425) | GlaxoSmithKline | 2018-04-11 |
| Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria (NCT02802501) | GlaxoSmithKline | 2018-04-08 |
| Biodistribution of 89Zirconium-labelled GSK2398852 Using PET Imaging (NCT03417830) | GlaxoSmithKline | 2018-04-06 |
| A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic Cough (NCT03372603) | GlaxoSmithKline | 2018-04-05 |
| A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03474081) | GlaxoSmithKline | 2018-03-29 |
| Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors (NCT03447314) | GlaxoSmithKline | 2018-03-26 |
| A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine (NCT03443427) | GlaxoSmithKline | 2018-03-20 |
| Efficacy and Safety Study of Sirukumab in Subjects With Polymyalgia Rheumatica (NCT02899026) | GlaxoSmithKline | 2018-03-15 |
| A Sourcing Study to Collect Human Blood Samples From Healthy Adults (NCT03493919) | GlaxoSmithKline | 2018-03-08 |
| The Efficacy of Fluticasone Furoate/Vilanterol Versus (vs) Fluticasone Furoate on Asthma (NCT03363191) | GlaxoSmithKline | 2018-03-07 |
| GSK1325756 Relative Bioavailability Study in Healthy Elderly Subjects (NCT03457727) | GlaxoSmithKline | 2018-03-07 |
| Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) (NCT03409107) | GlaxoSmithKline | 2018-03-05 |
| A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE (NCT03312907) | GlaxoSmithKline | 2018-03-01 |
| Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD) (NCT03359473) | GlaxoSmithKline | 2018-02-28 |
| A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 Study (NCT03355820) | GlaxoSmithKline | 2018-02-28 |
| A Dose-escalation Study in Subjects With Pulmonary Arterial Hypertension (PAH) (NCT03177603) | GlaxoSmithKline | 2018-02-21 |
| A Study to Evaluate the One Year Long-term Persistence of Immune Responses Following Two Different Rabies Vaccine Post-exposure Regimens in Chinese Children (NCT03192371) | GlaxoSmithKline | 2018-02-15 |
| Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting Conditions (NCT03408392) | GlaxoSmithKline | 2018-02-06 |
| A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic Subjects (NCT03380429) | GlaxoSmithKline | 2018-01-31 |
| Investigation of Thermal Injury on Intestinal Permeability in Both Thermal Injury and Healthy Participants (NCT03242434) | GlaxoSmithKline | 2018-01-29 |
| Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian Subjects (NCT03311659) | GlaxoSmithKline | 2018-01-26 |
| Targeted Literature Review and Subject Interviews in Wiskott-Aldrich Syndrome (WAS) (NCT03399461) | GlaxoSmithKline | 2018-01-24 |
| GSK2894512 Vehicle-Controlled Study for Adult Plaque Psoriasis (NCT03202004) | GlaxoSmithKline | 2018-01-22 |
| A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of Nemiralisib (NCT03398421) | GlaxoSmithKline | 2018-01-17 |
| BENLYSTA® Special Drug Use Investigation (NCT03370263) | GlaxoSmithKline | 2018-01-15 |
| GSK2983559 First Time in Human Study (NCT03358407) | GlaxoSmithKline | 2018-01-11 |
| A Bioequivalence Study of SKF101804 Cefixime Versus Cefixime Reference Formulation in Healthy Adults Under Fasting Conditions (NCT03329547) | GlaxoSmithKline | 2018-01-11 |
| Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years (NCT03273946) | GlaxoSmithKline | 2018-01-09 |
| Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function (NCT03351140) | GlaxoSmithKline | 2017-12-20 |
| Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461) (NCT03368053) | GlaxoSmithKline | 2017-12-14 |
| A Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of GSK2894512 in Healthy Adult Subjects (NCT03201978) | GlaxoSmithKline | 2017-12-14 |
| Burden of Disease Among Subjects With Eosinophilic Chronic Obstructive Pulmonary Disease (COPD) (NCT03436511) | GlaxoSmithKline | 2017-12-05 |
| Perceptions of Cell and Gene Therapies (CGT) for the Treatment of Cancer (NCT03336567) | GlaxoSmithKline | 2017-12-04 |
| Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants (NCT03128489) | GlaxoSmithKline | 2017-12-01 |
| A Study to Evaluate Conceptual Saturation of Evaluating Respiratory Symptoms (E-RS) in Subjects With Asthma (NCT03344406) | GlaxoSmithKline | 2017-12-01 |
| Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD) (NCT03345407) | GlaxoSmithKline | 2017-11-28 |
| A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. (NCT03281876) | GlaxoSmithKline | 2017-11-27 |
| Prevalence of Severe Asthma in Spanish Hospitals (NCT03137043) | GlaxoSmithKline | 2017-11-22 |
| Qualitative Research to Explore Treatment Preference in Pulmonary Arterial Hypertension (PAH) Subjects (NCT03304548) | GlaxoSmithKline | 2017-11-22 |
| Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease (NCT03136120) | GlaxoSmithKline | 2017-11-21 |
| A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture Wearers (NCT03345108) | GlaxoSmithKline | 2017-11-20 |
| A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal Hypersensitivity (NCT03310268) | GlaxoSmithKline | 2017-11-18 |
| Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD) (NCT03250689) | GlaxoSmithKline | 2017-11-15 |
| Absorption & Elimination of Radiolabelled GSK2269557 (NCT03315559) | GlaxoSmithKline | 2017-11-14 |
| A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 (NCT03306043) | GlaxoSmithKline | 2017-11-13 |
| In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste (NCT03296072) | GlaxoSmithKline | 2017-11-13 |
| Safety and Efficacy Study of Fluticasone Furoate/Vilanterol (FF/VI) Fixed Dose Combination (FDC) Compared to FF Alone in Subjects With Asthma (NCT03248128) | GlaxoSmithKline | 2017-10-20 |
| Pediatric Ease of Use ELLIPTA Items (NCT03315572) | GlaxoSmithKline | 2017-10-17 |
| First Time in Human (FTIH) Study to Evaluate Safety, Tolerability, Immunogenicity, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK3511294 Administered Subcutaneously (SC) in Subjects With Mild to Moderate Asthma (NCT03287310) | GlaxoSmithKline | 2017-10-17 |
| A Pilot Study of Danirixin for Disease Progression in Chronic Obstructive Pulmonary Disease (COPD) (NCT03170232) | GlaxoSmithKline | 2017-10-16 |
| A Safety and Pharmacokinetic (PK) Study of GSK2982772 in Healthy Subjects (NCT03305419) | GlaxoSmithKline | 2017-10-11 |
| Absorption and Elimination of Radiolabeled Daprodustat (NCT03239522) | GlaxoSmithKline | 2017-10-10 |
| The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine (NCT03294135) | GlaxoSmithKline | 2017-10-05 |
| A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B (NCT03258710) | GlaxoSmithKline | 2017-10-02 |
| Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers (NCT02130661) | GlaxoSmithKline | 2017-10-01 |
| Efficacy, Safety and Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine (SB257049) Evaluating Schedules With or Without Fractional Doses, Early Dose 4 and Yearly Doses, in Children 5-17 Months of Age (NCT03276962) | GlaxoSmithKline | 2017-09-28 |
| A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses (NCT03266172) | GlaxoSmithKline | 2017-09-27 |
| A Study to Investigate the Stain and Plaque Removal Capability of Two Experimental Potassium Nitrate Dentifrices (NCT03267511) | GlaxoSmithKline | 2017-09-25 |
| Phase I Study of Pyrimethamine in Healthy Japanese and Caucasian Subjects (NCT03258762) | GlaxoSmithKline | 2017-09-25 |
| Comparative Study of ELLIPTA Dry Powder Inhaler (DPI) Versus DISKUS DPI Used With HandiHaler DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT03227445) | GlaxoSmithKline | 2017-09-20 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Proof of Mechanism of GSK2618960 in Primary Sjögren's Syndrome (pSS) (NCT03239600) | GlaxoSmithKline | 2017-09-19 |
| To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population (NCT02937636) | GlaxoSmithKline | 2017-09-19 |
| This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine (NCT03207750) | GlaxoSmithKline | 2017-09-14 |
| Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England (NCT03278067) | GlaxoSmithKline | 2017-09-12 |
| Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015 (NCT02885246) | GlaxoSmithKline | 2017-09-11 |
| A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years (NCT03275389) | GlaxoSmithKline | 2017-09-08 |